col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


25 Results       Page 1

 [1] 
Elsevier: Cell Metabolism
  original article Date Title Authors   All Authors
1 [GO] 2023―Mar―01 The Effects of Obesity and Metabolic Abnormalities on Severe COVID-19-related Outcomes after Vaccination: A Population-Based Study Xiude Fan, Junming Han, Enfa Zhao, Jiansong Fang, Dawei Wang, Yiping Cheng, et al. (+10)
2 [GO] 2022―May―12 A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells Elena Garreta, Patricia Prado, Megan L. Stanifer, Vanessa Monteil, Andrés Marco, Asier Ullate-Agote, et al. (+21)
3 [GO] 2022―Mar―01 SARS-CoV-2 pirates the kidneys: A scar(y) story Jochen Reiser, Ryan Spear, Shengyuan Luo
4 [GO] 2022―Feb―11 Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry Zilun Li, Meixiu Peng, Pin Chen, Chenshu Liu, Ao Hu, Yixin Zhang, et al. (+25)
5 [GO] 2021―Dec―10 Replication of SARS-CoV-2 in adipose tissue determines organ and systemic lipid metabolism in hamsters and humans Martin Zickler, Stephanie Stanelle-Bertram, Sandra Ehret, Fabian Heinrich, Philine Lange, Berfin Schaumburg, et al. (+18)
6 [GO] 2021―Dec―07 Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 Moritz Reiterer, Mangala Rajan, Nicolás Gómez-Banoy, Jennifer D. Lau, Luis G. Gomez-Escobar, Lunkun Ma, et al. (+22)
7 [GO] 2021―Sep―16 Hyperglycemia in Acute COVID-19 is Characterized by Insulin Resistance and Adipose Tissue Infectivity by SARS-CoV-2 Moritz Reiterer, Mangala Rajan, Nicolás Gómez-Banoy, Jennifer D. Lau, Luis G. Gomez-Escobar, Lunkun Ma, et al. (+22)
8 [GO] 2021―May―19 SARS-CoV-2 Infection Induces Beta Cell Transdifferentiation Xuming Tang, Skyler Uhl, Tuo Zhang, Dongxiang Xue, Bo Li, J. Jeya Vandana, et al. (+19)
9 [GO] 2021―May―18 SARS-CoV-2 infects human pancreatic β-cells and elicits β-cell impairment Chien-Ting Wu, Peter V. Lidsky, Yinghong Xiao, Ivan T. Lee, Ran Cheng, Tsuguhisa Nakayama, et al. (+15)
10 [GO] 2021―Feb―09 COVID-19 and metabolic diseases: A heightened awareness of health inequities and a renewed focus for research priorities William T. Cefalu, Griffin P. Rodgers
11 [GO] 2021―Jan―22 Diabetes, obesity, metabolism and SARS-CoV-2 infection: The end of the beginning Daniel J. Drucker
12 [GO] 2021―Jan―14 COVID-19, obesity, and structural racism: Understanding the past and identifying solutions for the future Sara N. Bleich, Jamy D. Ard
13 [GO] 2021―Jan―10 The neutrophil-to-lymphocyte ratio determines clinical efficacy of corticosteroid therapy in patients with COVID-19 Jingjing Cai, Haomiao Li, Changjiang Zhang, Ze Chen, Hui Liu, Fang Lei, et al. (+33)
14 [GO] 2020―Nov―24 Glucose or insulin, which is the culprit in patients with covid-19 and diabetes? Marc Y. Donath
15 [GO] 2020―Nov―23 Insulin treatment is associated with increased mortality in patients with COVID-19 Bo Yu, Chenze Li, Yang Sun, Dao Wen Wang
16 [GO] 2020―Nov―13 Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19 Irina Kusmartseva, Wenting Wu, Farooq Syed, Verena Van Der Heide, Marda Jorgensen, Paul Joseph, et al. (+15)
17 [GO] 2020―Nov―13 SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 are Expressed in the Microvasculature and Ducts of Human Pancreas but are Not Enriched in β Cells Katie C. Coate, Jeeyeon Cha, Shristi Shrestha, Wenliang Wang, Luciana Mateus Gonçalves, Joana Almaça, et al. (+13)
18 [GO] 2020―Sep―11 Shining Light on the COVID-19 Pandemic: A Vitamin D Receptor Checkpoint in Defense of Unregulated Wound Healing Ronald M. Evans, Scott M. Lippman
19 [GO] 2020―Sep―01 Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis Ana Campos Codo, Gustavo Gastão Davanzo, Lauar de Brito Monteiro, Gabriela Fabiano de Souza, Stéfanie Primon Muraro, João Victor Virgilio-da-Silva, et al. (+38)
20 [GO] 2020―Aug―20 Metformin Use Is Associated with Increased Incidence of Acidosis but not Mortality in Individuals with COVID-19 and Pre-existing Type 2 Diabetes Xu Cheng, Ye-Mao Liu, Haomiao Li, Xin Zhang, Fang Lei, Juan-Juan Qin, et al. (+29)
21 [GO] 2020―Aug―04 Teaching Old Drugs New Tricks: Statins for COVID-19? David C. Fajgenbaum, Daniel J. Rader
22 [GO] 2020―Jul―17 Title: Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis dependent axis Ana Campos Codo, Gustavo Gastão Davanzo, Lauar de Brito Monteiro, Gabriela Fabiano de Souza, Stéfanie Primon Muraro, João Victor Virgilio-da-Silva, et al. (+38)
23 [GO] 2020―Jun―24 In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19 Xiao-Jing Zhang, Juan-Juan Qin, Xu Cheng, Lijun Shen, Yan-Ci Zhao, Yufeng Yuan, et al. (+43)
24 [GO] 2020―Jun―24 Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis. Jin-Wen Song, Sin Man Lam, Xing Fan, Wen-Jing Cao, Si-Yu Wang, He Tian, et al. (+17)
25 [GO] 2020―May―01 Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes Lihua Zhu, Zhi-Gang She, Xu Cheng, Juan-Juan Qin, Xiao-Jing Zhang, Jingjing Cai, et al. (+38)
 [1] 

25 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec